Industry News: GE tunes into European concerns

March 9, 2009

Focusing on company technologies aimed at early stage diagnosis, GE Healthcare is advocating disease prevention and presymptomatic detection at the ECR this week. In the context of this “Early Health” model of care, GE addressed an issue Europeans were the first to be concerned about: patient radiation dose.

Focusing on company technologies aimed at early stage diagnosis, GE Healthcare is advocating disease prevention and presymptomatic detection at the ECR this week. In the context of this “Early Health” model of care, GE addressed an issue Europeans were the first to be concerned about: patient radiation dose. The company showcased its Discovery CT750 HD, optimized to cut patient radiation to a fraction of the typically applied dose. GE also focused attention on the new low-dose version of its LightSpeed VCT, the Lightspeed XTe.

GE also highlighted its flagship ultrasound scanner, the Logiq E9, released late last year and shown at RSNA 2009. Aside from bringing premium technologies to conventional applications, the E9 fuses real-time ultrasound images into those derived from CT, MR and PET/CT scans.